•  
  •  
  •  
  •  

2026-07-20 07:29:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  CEP

Stock Report

  • Akums Receives European CEP Approval for Cefpodoxime Proxetil
  • IOL Chemicals and Pharmaceuticals Ltd granted EDQM CEP for Metformin Hydrochloride Process-II
  • IOL Chemicals and Pharmaceuticals Ltd gets EDQM's CEP for API Clopidogrel Besilate
  • EDQM issues CEP Certificate for MINOXIDIL to IOL Chemicals & Pharmaceuticals Ltd
  • Anuh Pharma Ltd granted CEP from EDQM for Sulfadimethoxine
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Sigachi Industries Ltd receives CEP for Metformin Hydrochloride from EDQM
  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Teriflunomide
  • EDQM issued CEP Certificate for MESALAZINE
  • Sigachi Industries Ltd arm receives CEP from EDQM for Propafenone Hydrochloride
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Nifedipine
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Octreotide
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Desmopressin
  • Wanbury Ltd received CEP approval from EDQM for the launch of its new product, Dextromethorphan API
  • Shilpa Pharma Lifesciences Ltd received CEP from EDQM for API, Ursodeoxycholic Acid
  • EDQM issues CEP certificate to IOL Chemicals and Pharmaceuticals Ltd for Valsartan
  • NGL Fine-Chem Limited receives CEP from EDQM for TRICLABENDAZOLE
  • Anuh Pharma Ltd receives EDQM approval for CEP of Sulfadoxine API
  • Shivalik Rasayan Ltd files CEP for Europe
  • Anuh Pharma Limited receives EDQM approval for CEP of Azithromycin API
  • IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European Market
  • Solara receives European Approval to manufacture Ibuprofen from its flagship Vizag Facility

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025